The global market of disposable endoscopes, which was valued at US$0.84 billion in 2024, has experienced a remarkable growth reaching to US$0.95 billion in 2025, and is projected to soar at a resilient compound annual growth rate (CAGR) of 22.9% from 2025 to 2030, reaching a projected valuation of US$2.67 billion at the end of the period. This significant growth can be attributed to numerous factors including the increasing demand for minimally invasive procedures, the rising prevalence of various chronic diseases such as neurological and respiratory disorders, and major technological advancements that enhance image quality and maneuverability of these devices. Additionally, the increase in the global geriatric population and improved reimbursement policies also contribute to the widespread adoption of disposable endoscopes. However, the high cost of these devices, risks associated with cross-contamination (despite reprocessing efforts) and the availability of alternative diagnostic techniques have been identified as obstacles to its continued market growth.
In terms of type, disposable endoscopes are divided into various categories including urology endoscopes, bronchoscopes, cystoscopes, laryngoscopes, GI endoscopes, arthroscopes, among others. Among these, the urology endoscopes held the largest market share in 2024 due to the increase in prevalence of chronic kidney and ureteral diseases and the rising incidences of prostate disorders. As a result, urology endoscopes, such as ureteroscopes, nephroscopes, resectoscopes, and urethroscopes, are widely used for diagnosis and treatment of these conditions. Given the infection control benefits and ease of use of disposable urology endoscopes, they have been recognized as instrumental in handling the growing procedural volume in healthcare settings which subsequently drives their dominant market share.
Analyzing the market by end user, hospitals, ambulatory surgical centers, clinics, and other service providers emerge as key segments. The hospital segment was found to hold the largest market share in 2024 due to the high volume of diagnostic and therapeutic procedures being performed. Hospitals serve as primary centers for executing advanced and complex endoscopic interventions across specialties like gastroenterology, urology, and pulmonology. The constant push for infection control measures and an increased preference for single-use endoscopes to avoid cross-contamination risks further boost the market in this sector.
Geographical analysis of the disposable endoscopes market reveals that in 2024, North America held the largest share of the global market. This position is maintained due to factors such as high prevalence of chronic diseases, an aging population, and rising procedural volumes across different specialties. Furthermore, a significant contribution to North America’s market leadership comes from the initiatives by the Food and Drug Administration (FDA) which promotes infection prevention through single-use endoscopes.
Top players in the global disposable endoscopes market include Olympus Corporation, Boston Scientific Corporation, HOYA Corporation, Ambu A/s, Karl Storz SE & Co. KG, Hunan Vathin Medical Instrument Co., Ltd., Scivita Medical, and Innovex Medical Co., Ltd. Companies such as Ambu A/S and Boston Scientific Corporation have asserted themselves as leaders in the market due to their strong product lineup, constant drive for innovation, and strategic regulatory achievements.